It is particularly important to report heart rate changes if you have pre-existing cardiovascular disease, a history of arrhythmias, or other significant cardiac risk factors
[11] [12] Currently available GLP-1 receptor agonists in the United States include semaglutide (Ozempic, Wegovy, Rybelsus), dulaglutide (Trulicity), liraglutide (Victoza, Saxenda), exenatide (Byetta, Bydureon BCise), and tirzepatide (Mounjaro, Zepbound)though tirzepatide is technically a dual GLP-1/GIP receptor agonist
Su QJ, Ashenhurst JR, Xu W, et al
This commitment ensures that out-of-state and international patients can focus fully on their recovery without added travel expenses
These actions lower blood sugar levels and suppress appetite, aiding in weight loss
Heres a simplified approach: 1